NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, Nina Bhardwaj, Andrew Charap et al.|Cancer Cell|2022Cited by 127
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGürkan Mollaoglu, Brian D. Brown, Alexander Tepper et al.|Cell|2024Cited by 99
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancerPhilip C. Mack, Jorge Gómez, Ananda M. Rodilla et al.|Cancer Cell|2022Cited by 18